Adaptimmune Therapeutics plcAdaptimmune Therapeutics plcAdaptimmune Therapeutics plc

Adaptimmune Therapeutics plc

No trades
See on Supercharts

ADAP fundamentals

Adaptimmune Therapeutics plc earnings per share and revenue

ADAP earnings per share for the last quarter are 0.04 USD whereas the estimation was -0.04 USD which accounts for 191.30% surprise. Company revenue for the same period amounts to 128.23 M USD despite the estimated figure of 40.47 M USD. Estimated earnings per share for the next quarter are -0.01 USD, and revenue is expected to reach 18.57 M USD. Also watch annual changes over time to get a bigger picture of ADAP earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Revenue
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise